No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
284 |
4. Check minimum number of eventsNone |
284 |
5. Include endpointsNone |
284 |
6. Filter based on genotype QC (FinnGen only) |
284 |
Control definitions (FinnGen only)
- Control exclude
- M13_ARTHROPATHIES
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M21
- Name in latin
- Deformitas membri valga non alibi classificata
Similar endpoints
↥List of similar endpoints to
Valgus deformity, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Other joint disorders
- Arthropathies
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2937 | 1838 | 1089 |
| Only index persons | 2579 | 1613 | 966 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.05 | 0.03 |
| Only index persons | 0.05 | 0.06 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 35.31 | 47.23 | 14.96 |
| Only index persons | 34.02 | 45.33 | 15.13 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 284 | 201 | 83 |
| Unadjusted period prevalence (%) | 0.06 | 0.07 | 0.04 |
| Median age at first event (years) | 40.54 | 45.50 | 28.50 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 255
- Matched controls
- 2549
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M21.0
ICD-10 Finland
Valgus deformity, not elsewhere classified
+∞
250.0
197
*
M20.1
ICD-10 Finland
Hallux valgus (acquired)
131.8
72.6
75
8
M17.1
ICD-10 Finland
Other primary gonarthrosis
38.8
47.6
60
20
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
191.0
46.5
47
*
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
+∞
45.2
42
*
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
+∞
39.6
37
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
21.4
37.6
56
33
M19.0
ICD-10 Finland
Primary arthrosis of other joints
80.9
37.2
41
6
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
+∞
27.6
26
*
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
+∞
27.6
26
*
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
52.0
27.2
32
7
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
22.5
25.7
37
19
M25.5
ICD-10 Finland
Pain in joint
5.7
25.3
83
199
73802
ICD-8 Finland
Other deformities, Genu valgum
+∞
21.1
20
*
NHK40
NOMESCO Finland
Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone
227.8
20.9
21
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
10.6
20.8
41
45
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
52.7
20.5
24
5
M01AX05
ATC
glucosamine; oral
5.8
19.7
60
128
ZXA00
NOMESCO Finland
Right side
4.1
19.0
88
291
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
35.9
18.3
23
7
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
+∞
17.9
17
*
NHG26
NOMESCO Finland
Fusion between bones of ankle or ankle and foot
+∞
17.9
17
*
N02AX02
ATC
tramadol; systemic, rectal
3.4
17.9
114
484
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
15.6
17.3
28
20
M20.2
ICD-10 Finland
Hallux rigidus
+∞
16.9
16
*
M13.9
ICD-10 Finland
Arthritis, unspecified
19.6
16.8
25
14
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
181.4
16.7
17
*
M16.1
ICD-10 Finland
Other primary coxarthrosis
43.2
16.6
20
5
WX320
NOMESCO Finland
Spinalanesthesy
4.6
16.2
62
168
M79.6
ICD-10 Finland
Pain in limb
3.3
16.1
106
452
L15
ICPC
Knee symptom/complaint
4.3
15.9
65
188
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
90.8
15.8
17
*
N03AX12
ATC
gabapentin; oral
5.0
15.6
54
131
M01AH05
ATC
etoricoxib; oral
3.0
15.6
149
817
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.1
15.5
123
595
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
10.4
14.9
29
31
NGU20
NOMESCO Finland
Removal of internal fixation device from knee or lower leg
20.6
14.5
21
11
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
32.1
14.1
18
6
ZXA05
NOMESCO Finland
Left side
3.5
13.9
75
272
73800
ICD-8 Finland
Other deformities, Coxa valga
+∞
13.7
13
*
NFK30
NOMESCO Finland
Angulation, rotation or displacement osteotomy of femur
+∞
13.7
13
*
9271
FHL
Hallux surgery
+∞
13.7
13
*
NFK20
NOMESCO Finland
Epiphysiodesis of femur
+∞
13.7
13
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
9.9
13.1
26
29
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
25.9
12.6
17
7
NHG70
NOMESCO Finland
Arthroplasty of first tarsometatarsal joint
+∞
12.6
12
*
7364A
ICD-9 Finland
Other acquired deformities of limbs, Genu valgum or varum (acquired)[GENU VALGUM ACQUISITUM]
+∞
12.6
12
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
5.2
12.4
39
85
NFU20
NOMESCO Finland
Removal of internal fixation device from femur
39.7
12.3
15
*
L17
ICPC
Foot/toe symptom/complaint
3.0
11.8
81
343
NHL68
NOMESCO Finland
Tenodesis, shortening or lengthening of tendon of foot
+∞
11.5
11
*
M17.3
ICD-10 Finland
Other post-traumatic gonarthrosis
125.4
11.5
12
*
N03AX16
ATC
pregabalin; oral
3.3
11.5
66
246
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
45.4
11.0
13
*
N02AJ06
ATC
codeine and paracetamol; systemic
2.7
10.9
94
453
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.7
10.5
48
150
NHG82
NOMESCO Finland
Fusion of other tarsal joint
114.5
10.5
11
*
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
114.5
10.5
11
*
7350A
ICD-9 Finland
Acquired deformities of toe, Hallux valgus (acquired)
+∞
10.5
10
*
7151F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]
+∞
10.5
10
*
M21.1
ICD-10 Finland
Varus deformity, not elsewhere classified
+∞
10.5
10
*
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
+∞
10.5
10
*
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
6.5
10.1
26
44
NH3EA
NOMESCO Finland
Feet X-ray examination with load
27.3
9.9
13
5
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
5.4
9.8
29
59
B01AF01
ATC
rivaroxaban; oral
5.2
9.7
30
64
M18.1
ICD-10 Finland
Other primary arthrosis of first carpometacarpal joint
57.2
9.7
11
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
15.8
9.6
15
10
S18
ICPC
Laceration/cut
2.4
9.6
105
570
NHL99
NOMESCO Finland
Other operation on muscle or tendon of ankle or foot
+∞
9.4
9
*
J01FF01
ATC
clindamycin; systemic
2.7
9.4
75
341
L28
ICPC
Limited function/disability (L)
3.6
9.4
43
135
WX702
NOMESCO Finland
Supraglottic ventilation device
6.0
9.3
25
45
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
8.5
9.0
19
24
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.6
9.0
76
359
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
7.7
8.9
20
28
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
11.3
8.9
16
15
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
6.1
8.7
23
41
NGK30
NOMESCO Finland
Angulation, rotation or displacement osteotomy of knee or lower leg
93.0
8.5
9
*
M22.0
ICD-10 Finland
Recurrent dislocation of patella
93.0
8.5
9
*
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
93.0
8.5
9
*
NHL14
NOMESCO Finland
Shortening or lengthening of achilles tendon
93.0
8.5
9
*
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
+∞
8.4
8
*
NG1DA
NOMESCO Finland
X-ray of knees
+∞
8.4
8
*
B01AB05
ATC
enoxaparin; parenteral
2.6
8.3
69
320
P01BA02
ATC
hydroxychloroquine; oral
7.2
8.2
19
28
N02BE01
ATC
paracetamol; systemic, rectal
2.5
8.2
209
1645
NFB40
NOMESCO Finland
Primary total prosthetic replacement of hip joint using hybrid technique
34.5
8.1
10
*
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
22.9
8.1
11
5
N06AX21
ATC
duloxetine; oral
3.7
8.1
35
105
M54.5
ICD-10 Finland
Low back pain
2.4
8.0
80
407
1221
FHL
Arthroscopy and meniscus surgery
46.4
7.8
9
*
M67.0
ICD-10 Finland
Short Achilles tendon (acquired)
46.4
7.8
9
*
E66.00
ICD-10 Finland
Metabolic syndrome
5.5
7.8
22
43
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.9
7.6
24
53
M01AB05
ATC
diclofenac; systemic, rectal
2.1
7.5
154
1076
H02AB06
ATC
prednisolone; systemic
2.1
7.5
108
651
N06AA09
ATC
amitriptyline; systemic
3.9
7.4
30
85
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
6.6
7.4
18
29
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
+∞
7.3
7
*
Q74.1
ICD-10 Finland
Congenital malformation of knee
+∞
7.3
7
*
7363A
ICD-9 Finland
Other acquired deformities of limbs, Acquired deformities of hip[COXA VALGA ACQUISITA]
+∞
7.3
7
*
M23.3
ICD-10 Finland
Other meniscus derangements
+∞
7.3
7
*
NHG22
NOMESCO Finland
Fusion of subtalar joint
+∞
7.3
7
*
7360A
ICD-9 Finland
Other acquired deformities of limbs, Acquired deformities of forearm, excluding fingers[CUBITUS VALGUS ACQUISITUS]
+∞
7.3
7
*
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
+∞
7.3
7
*
NHG24
NOMESCO Finland
Fusion of subtalar joint and between bones of ankle
+∞
7.3
7
*
M70.6
ICD-10 Finland
Trochanteric bursitis
3.6
7.1
32
99
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.9
7.1
28
78
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
7.0
96
562
L13
ICPC
Hip symptom/complaint
3.3
7.0
34
112
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
14.3
7.0
11
8
9165
FHL
Removal of osteosynthesis material
14.3
7.0
11
8
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
4.6
6.9
23
54
9273
FHL
Other surgery for toe deformity or pain condition, e.g., Morton, hammer toe
41.2
6.8
8
*
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
41.2
6.8
8
*
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
41.2
6.8
8
*
NHK10
NOMESCO Finland
Incision or excision of metatarsal or tarsal bone
41.2
6.8
8
*
R03BA01
ATC
beclometasone; inhalant
2.8
6.8
43
170
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.8
6.8
28
81
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
6.8
6.8
16
25
G57.6
ICD-10 Finland
Lesion of plantar nerve
12.7
6.6
11
9
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
5.3
6.6
19
38
J45.9
ICD-10 Finland
Asthma, unspecified
2.6
6.6
50
217
TQW40
NOMESCO Finland
Remowal of suture of skin
4.5
6.6
22
52
M01AC06
ATC
meloxicam; systemic, rectal
2.2
6.6
82
458
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
4.4
6.5
22
53
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
6.5
71
375
SAA01
NOMESCO Finland
Simple examination of mouth
2.1
6.5
186
1444
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.6
6.5
49
213
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
8.5
6.4
13
16
M19.8
ICD-10 Finland
Other specified arthrosis
11.4
6.4
11
10
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
11.4
6.4
11
10
J01DA01
ATC
[U] cefalexin; systemic
2.0
6.3
155
1129
SPAT1153
SPAT
Removal of sutures
2.2
6.3
72
387
NH1EA
NOMESCO Finland
Ankle X-ray examination with load or wrench
+∞
6.3
6
*
NHK68
NOMESCO Finland
Shortening or lengthening osteotomy of ankle or foot
+∞
6.3
6
*
7177A
ICD-9 Finland
Internal derangement of knee, Chondromalacia of patella
+∞
6.3
6
*
Q66.0
ICD-10 Finland
Talipes equinovarus
+∞
6.3
6
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.3
6.3
31
104
A02BC01
ATC
omeprazole; systemic
2.2
6.2
66
343
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
12.9
6.1
10
8
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
10.4
6.1
11
11
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
6.0
108
697
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
158
897
2.72
15.28
3.9
3.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
67
282
2.80
11.19
1.3
1.2
iu/ml
17.7
15.1
0.17
18
83
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
63
259
2.84
10.98
1.3
1.1
u/ml
22.4
1.3
0.81
19
108
(3013707) Erythrocyte sedimentation rate by Westergren method
210
1510
2.50
10.53
4.8
3.1
mm/h
10.2
10.7
0.30
198
1366
(3042936) Bacteria identified in Isolate by Culture
54
239
2.56
8.01
1.7
2.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
120
759
2.01
7.37
2.2
1.8
pmol/l
94.2
95.9
0.16
66
373
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
16
7.11
7.20
1.4
1.1
—
—
—
0
0
(4024509)
10
14
7.37
6.74
2.0
1.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
204
1592
2.00
6.39
7.1
6.9
u/l
79.8
77.9
0.25
196
1471
(3025159) Blasts/100 leukocytes in Blood
34
136
2.70
6.13
4.7
4.2
%
0.0
0.0
—
7
39
(3044640) Blood type and Crossmatch panel - Blood
97
602
1.93
6.07
2.5
2.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
141
993
1.83
5.89
10.5
6.9
mmol/l
1.2
1.2
0.08
122
846
(3032080) INR in Blood by Coagulation assay
113
744
1.86
5.85
9.6
7.3
inr
1.2
1.2
0.07
42
233
(3021440) Promyelocytes/100 leukocytes in Blood
34
144
2.55
5.48
4.7
4.1
%
0.0
0.2
—
7
49
(3017181) Myelocytes/100 leukocytes in Blood
35
155
2.43
5.14
4.6
4.1
%
0.3
0.8
—
7
54
(3008898) HLA-B27 [Presence]
17
50
3.55
5.11
1.0
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
122
849
1.77
5.10
2.9
2.3
nmol/l
75.8
75.8
0.00
110
750
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
106
709
1.79
5.07
3.1
3.2
ng/l
24.3
95.1
0.70
72
447
(3024561) Albumin [Mass/volume] in Serum or Plasma
117
806
1.77
5.06
5.6
5.4
g/l
35.8
36.1
0.25
106
755
(3021960) Folate [Moles/volume] in Serum or Plasma
73
436
1.91
5.01
1.6
1.4
nmol/l
22.6
21.5
0.26
67
366
(3005322) IgE [Units/volume] in Serum or Plasma
30
126
2.54
4.92
1.2
1.2
u/ml
140.0
419.8
0.80
25
112
(42870588) Differential panel, method unspecified - Blood
98
647
1.79
4.86
8.9
5.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
134
975
1.71
4.67
7.9
5.1
%
2.7
2.9
0.69
120
902
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
143
1060
1.70
4.65
5.3
6.7
umol/l
10.1
10.9
0.72
136
1003
(3019550) Sodium [Moles/volume] in Serum or Plasma
257
2274
2.37
4.56
19.0
13.3
mmol/l
139.7
139.7
0.12
251
2199
(3019069) Monocytes/100 leukocytes in Blood
134
981
1.69
4.53
8.1
5.4
%
8.3
8.4
0.09
122
916
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
70
426
1.85
4.49
3.1
1.6
mg/l
1.4
1.0
0.67
52
313
(3045414) Leukocytes [Presence] in Urine
23
89
2.72
4.43
3.3
1.8
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
257
2281
2.33
4.40
19.0
13.4
mmol/l
3.9
3.9
0.30
250
2203
(3013826) Glucose [Moles/volume] in Serum or Plasma
157
1205
1.68
4.39
6.4
4.8
mmol/l
6.2
6.5
2.23
146
1103
(3022096) Basophils/100 leukocytes in Blood
129
943
1.67
4.33
8.0
5.2
%
0.6
0.7
1.20
117
874
(3002179) Metamyelocytes/100 leukocytes in Blood
30
136
2.35
4.19
4.7
4.0
%
0.2
0.3
—
6
34
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
124
903
1.66
4.18
10.2
6.2
mmol/l
1.2
1.2
0.02
112
826
(3018010) Neutrophils/100 leukocytes in Blood
134
1001
1.64
4.06
7.5
5.0
%
55.1
55.6
0.18
123
938
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
72
456
1.78
4.02
2.3
2.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
89
602
1.70
3.93
3.2
3.0
mmol/l
8.1
7.4
0.50
78
514
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
11
7.45
3.88
7.3
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
40
211
2.04
3.87
1.7
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
14
44
3.29
3.83
3.3
2.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
182
1486
1.63
3.71
6.1
3.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
136
1036
1.60
3.70
7.6
5.0
e9/l
0.0
0.0
0.90
120
880
(3013115) Eosinophils [#/volume] in Blood
141
1084
1.60
3.69
8.3
5.4
e9/l
0.2
0.2
1.20
123
932
(3001604) Monocytes [#/volume] in Blood
134
1029
1.57
3.46
7.7
5.0
e9/l
0.6
0.6
0.22
118
871
(3022217) INR in Platelet poor plasma by Coagulation assay
39
213
1.96
3.44
15.7
16.2
inr
1.7
1.2
—
5
36
(3002030) Lymphocytes/100 leukocytes in Blood
133
1021
1.57
3.43
8.1
5.1
%
30.2
29.7
0.21
122
949
(3026493) Urate [Moles/volume] in Serum or Plasma
63
402
1.73
3.39
3.4
2.6
umol/l
353.8
13245.4
3.64
57
357
(3026008) Bacteria identified in Urine by Culture
92
650
1.61
3.36
4.2
2.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
90
633
1.62
3.35
2.1
2.4
u/l
53.2
56.8
0.50
84
582
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
97
697
1.59
3.29
4.9
2.9
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
9
19
4.85
3.26
1.2
1.7
ug/l
14.4
19.0
—
9
19
(3019309) Folate [Moles/volume] in Red Blood Cells
52
320
1.77
3.17
1.8
1.6
nmol/l
1165.8
1188.1
0.07
46
232
(3002256) Pathology report gross observation
44
258
1.83
3.14
1.2
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
26
126
2.17
3.14
1.3
1.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
17
68
2.60
3.10
21.6
5.3
mg/l
1.3
1.4
0.12
17
63
(3019230) Fractional oxyhemoglobin in Venous blood
10
29
3.54
3.07
30.4
7.7
%
76.3
64.5
—
10
29
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
13
45
2.98
3.06
1.2
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
72
489
1.63
3.05
2.5
2.1
mg/l
2.8
2.9
0.12
64
402
(3002582) Erythrocytes [#/volume] in Urine
83
585
1.59
3.02
5.6
3.0
e6/l
16.9
59.3
2.03
68
436
(3005719) IgG [Mass/volume] in Serum or Plasma
27
135
2.11
3.02
4.2
2.8
g/l
10.3
10.4
0.04
27
123
(3006653) Thiamine [Moles/volume] in Blood
5
5
10.15
2.99
1.2
1.2
nmol/l
153.8
123.6
—
5
5
(4010399)
29
150
2.04
2.97
1.4
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
10
30
3.42
2.93
1.6
1.3
u/ml
4.6
3.6
—
5
18
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
15
58
2.67
2.92
1.3
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
35
195
1.91
2.92
1.9
1.3
titre
217.1
453.0
—
7
40
(3013650) Neutrophils [#/volume] in Blood by Automated count
152
1231
1.51
2.91
9.3
8.8
e9/l
3.9
4.0
0.00
134
1053
(3019198) Lymphocytes [#/volume] in Blood
135
1069
1.50
2.87
7.7
5.0
e9/l
2.0
2.1
0.34
121
929
(3013512) EKG study
78
548
1.58
2.86
4.0
3.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
25
124
2.11
2.86
3.2
2.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
261
2406
2.05
2.83
15.9
10.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
128
1008
1.49
2.76
4.1
2.6
ug/l
85.3
97.1
0.52
120
921
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
78
553
1.57
2.74
1.4
1.3
u/ml
1.5
3.2
0.64
16
137
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
20
92
2.26
2.74
16.8
4.3
%
0.7
0.7
0.11
20
87
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
245
2220
1.75
2.73
16.6
11.4
mg/l
14.8
24.5
7.93
202
1646
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
234
2095
1.66
2.73
5.5
4.5
mu/l
1.8
1.9
0.94
219
1912
(3022313) Gas panel - Capillary blood
21
99
2.21
2.72
12.2
4.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
70
486
1.58
2.69
4.4
3.0
ng/l
1010.6
1052.1
0.05
56
413
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
222
1971
1.58
2.59
5.6
5.0
mmol/mol
37.6
38.9
1.84
208
1809
(3024354) Oxygen [Partial pressure] in Venous blood
31
173
1.89
2.59
15.2
4.2
kpa
5.4
4.6
0.59
31
167
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
6
11
5.54
2.55
1.0
1.6
mmol/l
1.6
1.6
—
6
11
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
33
3.10
2.55
1.2
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
58
390
1.61
2.54
6.6
2.5
mosm/kgh2o
586.7
553.3
0.42
51
326
(40768804) Tissue Pathology biopsy report
109
843
1.48
2.52
2.0
2.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
24
124
2.02
2.49
12.4
4.6
mmol/l
0.5
1.9
0.92
16
96
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
19
91
2.17
2.39
2.3
14.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
34
201
1.79
2.38
14.4
4.8
kpa
6.0
5.8
0.91
34
195
(3048929) Epstein Barr virus Ab [Presence] in Serum
18
86
2.17
2.28
1.9
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
46
300
1.64
2.27
4.5
2.7
e6/l
3.8
3.3
0.12
29
155
(3022948) Iron [Moles/volume] in Serum or Plasma
43
277
1.65
2.23
4.1
2.3
umol/l
15.2
14.0
0.48
38
254
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
261
2438
1.87
2.22
11.2
8.4
u/l
26.3
24.7
0.59
255
2337
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
235
2140
1.57
2.17
4.6
3.9
mmol/l
5.7
5.8
0.26
218
1947
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
30
3.06
2.16
1.2
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
123
996
1.41
2.15
13.3
7.6
e9/l
0.0
0.0
1.07
109
785
(3020682) Albumin/Creatinine [Ratio] in Urine
74
545
1.48
2.15
3.7
3.9
mg/mmol
8.2
9.7
0.13
44
342
(3018095) Leukocytes [#/volume] in Urine
91
698
1.45
2.14
7.6
3.4
e6/l
29.4
98.5
2.45
72
473
(3000492) Spirometry study
31
186
1.75
2.08
1.3
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
230
2092
1.52
2.06
14.2
10.2
ml/min/173m2
86.0
85.2
0.18
187
1668
(3000330) Specific gravity of Urine by Test strip
20
104
1.99
2.06
4.2
3.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
46
309
1.58
2.02
1.6
1.9
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
9
32
2.87
2.02
3.7
2.5
mmol/l
7.0
8.3
—
9
32
(3012516) Albumin [Mass/volume] in Urine
70
517
1.47
1.99
2.8
3.1
mg/l
1354.9
595.4
0.25
39
326
(3003694) ABO and Rh group [Type] in Blood
86
661
1.43
1.99
1.5
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
65
476
1.47
1.93
1.7
1.3
g/l
2.1
2.1
0.15
34
283
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
18
93
2.00
1.89
1.7
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
41
273
1.59
1.87
4.4
3.7
%
30.8
31.6
0.24
25
174
(3048689) Calprotectin [Mass/mass] in Stool
44
298
1.56
1.87
2.2
2.6
ug/g
175.6
112.4
0.55
30
227
(3037121) Protein [Mass/volume] in Urine
14
66
2.18
1.85
5.6
4.2
g/l
0.1
0.2
—
6
30
(3044941) Cell count panel - Synovial fluid
5
12
4.22
1.83
1.2
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
68
508
1.45
1.82
6.4
6.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
197
1757
1.40
1.82
4.7
3.8
pmol/l
14.9
14.7
0.85
176
1592
(3008037) Lactate [Moles/volume] in Venous blood
9
35
2.62
1.81
3.7
2.4
mmol/l
1.2
1.4
—
9
35
(3041096) Erythrocytes [Presence] in Urine by Automated
80
618
1.41
1.78
5.3
2.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
127
1063
1.35
1.72
5.7
3.2
estimate
0.0
0.0
0.00
35
186
(4306422)
8
31
2.63
1.67
1.4
1.3
—
—
—
0
0
(3019225) pH of Specimen
28
176
1.66
1.62
4.9
3.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
35
233
1.57
1.61
1.2
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
125
1056
1.33
1.56
7.0
4.5
estimate
0.0
0.0
0.50
36
190
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
54
398
1.44
1.55
1.5
1.7
pmol/l
145833716.9
444.2
0.49
48
332
(40760892) CBC W Ordered Manual Differential panel - Blood
64
487
1.41
1.54
5.6
4.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
65
496
1.40
1.54
4.3
4.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
23
139
1.71
1.54
1.5
1.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
9
37
2.48
1.49
6.9
1.2
mmol/l
72.8
61.2
—
9
30
(3035350) Ketones [Presence] in Urine by Test strip
124
1055
1.31
1.44
5.9
3.2
estimate
0.0
0.0
0.00
33
190
(3022806) Fractional oxyhemoglobin in Capillary blood
6
22
2.76
1.44
1.3
2.2
%
92.1
90.2
—
6
22
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
19
111
1.76
1.43
22.4
5.5
mmol/l
24.8
24.0
0.63
19
102
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
40
2.29
1.41
1.0
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
40
2.29
1.41
2.3
1.6
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
18
104
1.78
1.40
1.1
1.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
69
541
1.36
1.39
4.8
2.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
85
690
1.33
1.37
2.3
3.7
mmol/l
2.3
2.4
0.85
71
607
(3000093) Morphology [Interpretation] in Blood Narrative
5
17
2.97
1.36
1.2
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
61
2.01
1.35
1.2
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
270
2598
1.80
1.33
23.9
16.5
e9/l
262.0
255.1
0.93
263
2512
(3030467) Casts [#/volume] in Urine by Automated count
68
536
1.35
1.33
5.1
3.0
e6/l
0.2
0.5
1.13
54
390
(3019150) Specific gravity of Urine by Refractometry
62
482
1.37
1.32
4.7
3.4
kg/l
1.0
1.0
—
7
68
(3035637) Corticotropin [Mass/volume] in Plasma
6
24
2.53
1.31
2.5
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
24
2.53
1.31
2.8
2.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
34
2.39
1.30
1.1
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
33
229
1.50
1.29
1.6
1.8
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
18
2.81
1.29
57.8
11.2
%
12.2
11.6
—
5
18
(3026361) Erythrocytes [#/volume] in Blood
270
2601
1.77
1.28
23.9
16.5
e12/l
4.5
4.5
0.08
262
2516
(3027945) Reticulocytes/100 erythrocytes in Blood
29
196
1.53
1.28
4.3
3.4
%
1.6
1.7
0.24
23
173
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
9
44
2.08
1.28
3.7
2.7
u/ml
0.4
0.4
—
9
27
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
35
2.32
1.28
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
35
2.32
1.28
3.0
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
22
139
1.63
1.27
1.6
1.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
17
100
1.74
1.26
3.8
3.7
mmol/l
25.4
24.9
0.22
17
100
(3010813) Leukocytes [#/volume] in Blood
270
2602
1.76
1.26
23.9
16.6
e9/l
6.7
6.6
0.32
263
2511
(21494755) Public health laboratory ask at order entry panel
16
262
0.59
1.26
1.4
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
36
2.26
1.25
2.3
1.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
63
1.94
1.24
1.1
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
100
841
1.29
1.23
5.5
3.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
34
240
1.47
1.23
5.0
2.3
%
23.9
23.6
0.05
29
204
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
168
0.52
1.23
1.4
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
48
362
1.39
1.23
3.6
3.7
ng/l
193.4
434.3
0.68
31
263
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
19
2.66
1.22
1.0
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
71
1.87
1.21
2.0
1.7
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
8
38
2.14
1.19
2.6
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
26
2.33
1.19
1.5
1.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
10
50
2.04
1.18
2.3
1.4
—
1.0
—
0
5
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
53
410
1.36
1.17
4.9
4.5
ug/l
2.4
2.2
0.13
47
370
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
35
0.00
1.16
0.0
1.0
—
—
—
0
0
(4268621)
5
20
2.53
1.15
3.8
2.3
—
—
—
0
0
(4062490)
5
20
2.53
1.15
1.4
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
52
402
1.36
1.15
4.9
2.5
e6/l
11.6
6.0
0.69
46
349
(3052851) Hemolysis interference index of Serum or Plasma
11
58
1.93
1.13
2.3
2.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
31
219
1.47
1.13
1.5
2.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
40
2.03
1.13
2.8
1.4
—
—
—
0
0
(3010421) pH of Blood
8
41
1.98
1.09
12.4
3.0
ph
7.4
7.4
—
8
32
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
31
221
1.45
1.08
1.5
1.9
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
7
33
2.15
1.06
3.6
3.9
%
0.5
1.7
—
7
28
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
9
47
1.94
1.03
2.4
1.3
—
2.8
—
0
10
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
9
47
1.94
1.03
2.4
1.3
—
5.8
—
0
10
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
36
1.97
0.97
1.0
1.6
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
36
1.97
0.97
2.9
1.3
—
1.1
—
0
6
(3003338) MCHC [Mass/volume]
187
2006
0.80
0.97
20.8
15.0
g/l
333.4
332.7
0.44
187
1994
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
27
2.25
0.94
6.3
2.9
e9/l
4.0
4.1
—
6
27
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
55
1.85
0.93
2.6
1.7
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
6
28
2.17
0.92
2.3
1.7
mmol/l
1.8
1.6
—
6
28
(1616796) Gas panel - Central venous blood
6
28
2.17
0.92
18.7
3.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
19
127
1.53
0.91
2.3
2.6
e9/l
3.9
3.9
0.02
13
105
(3029937) Albumin [Presence] in Urine by Test strip
69
575
1.26
0.90
7.0
3.3
estimate
0.0
0.0
0.50
33
190
(3000991) Gas panel - Venous blood
25
178
1.44
0.90
7.7
7.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
29
2.09
0.90
8.8
3.7
%
59.3
54.3
—
6
29
(3009542) Hematocrit [Volume Fraction] of Blood
226
2140
1.27
0.88
18.2
12.5
%
39.7
40.0
0.14
149
1606
(3003396) Base excess in Arterial blood by calculation
27
196
1.42
0.88
3.0
9.7
mmol/l
-0.7
1.5
1.64
16
153
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
8
44
1.84
0.86
1.3
2.3
mg/l
12.2
12.1
—
8
38
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
25
180
1.43
0.85
3.1
2.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
67
561
1.25
0.84
1.6
1.6
mmol/l
1.4
1.3
0.19
62
466
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
32
242
1.36
0.83
6.0
6.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
32
1.89
0.82
19.3
2.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
47
1.72
0.81
37.5
6.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
30
226
1.37
0.80
1.2
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
33
1.84
0.79
1.3
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
34
262
1.34
0.79
1.2
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
74
1.65
0.79
1.8
1.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
40
316
1.31
0.79
3.1
2.5
e6/l
1.6
1.0
0.18
22
168
(36660697) Celiac disease serology panel - Serum
28
210
1.37
0.77
1.3
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
70
596
1.23
0.76
5.2
3.6
ph
7.4
7.4
0.05
15
107
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
229
2185
1.25
0.75
4.6
3.9
mmol/l
4.5
4.7
2.18
215
2026
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
24
2.10
0.75
3.0
2.5
—
—
—
0
0
(3044889) 12 lead EKG panel
159
1466
1.19
0.75
3.9
3.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
9
56
1.63
0.73
4.4
3.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
25
2.02
0.73
1.0
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
68
1.64
0.72
1.9
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
9
59
1.54
0.69
1.7
2.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
28
1.80
0.66
1.0
1.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
28
1.80
0.66
3.4
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
55
466
1.22
0.63
4.7
3.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
30
1.68
0.61
1.0
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
18
131
1.40
0.61
1.2
3.3
g/l
67.5
67.0
0.12
18
118
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
18.4
—
1506.1
—
0
20
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
13.5
—
802.1
—
0
20
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
21
275
0.74
0.60
1.4
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
1.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
17
123
1.41
0.59
1.5
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
17
123
1.41
0.59
1.5
1.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
10
64
1.58
0.59
1.3
2.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
35
1.73
0.58
1.3
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
35
1.73
0.58
7.7
3.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
17
124
1.39
0.57
1.5
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
6
36
1.68
0.57
1.0
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
31
249
1.27
0.57
2.7
2.5
ug/l
0.8
0.8
0.05
17
153
(3002523) Influenza virus A Ag [Presence] in Specimen
6
37
1.63
0.56
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
37
1.63
0.56
1.0
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
6
38
1.59
0.54
1.0
1.1
—
20.4
—
0
7
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
230
2220
1.19
0.51
4.8
4.3
mmol/l
2.7
2.8
1.30
212
2043
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
216
2075
1.17
0.51
4.0
3.6
mmol/l
1.3
1.2
0.87
201
1909
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
225
2170
1.18
0.50
4.5
3.9
mmol/l
1.4
1.5
1.67
210
1999
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
16
211
0.74
0.49
1.8
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
143
0.69
0.49
1.4
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
16
121
1.34
0.45
1.5
1.8
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
11
78
1.43
0.43
2.4
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
24
194
1.26
0.43
8.0
3.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
31
1.62
0.43
1.2
1.6
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
5
32
1.57
0.42
1.0
1.0
—
2.4
—
0
17
(3004588) Protein electrophoresis panel - Serum or Plasma
14
105
1.35
0.42
1.4
2.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
56
496
1.16
0.41
1.6
1.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
169
1612
1.12
0.39
3.3
3.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
9
71
1.28
0.36
1.8
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
12
90
1.35
0.36
2.5
2.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
6
41
1.47
0.36
4.3
3.7
umol/l
7.1
5.6
—
6
32
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
45
1.34
0.34
1.0
1.8
—
—
—
0
0
(4094501)
6
45
1.34
0.34
1.5
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
25
295
0.83
0.34
1.8
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
39
342
1.16
0.33
3.6
4.4
%
19.9
20.4
0.08
18
156
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
6
86
0.69
0.33
2.3
3.5
u/ml
5.7
1686.6
—
6
76
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
110
1.29
0.32
1.5
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
98
0.71
0.31
1.7
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
11
84
1.32
0.30
1.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
10
128
0.77
0.27
2.2
1.7
—
—
—
0
0
(4035726)
15
181
0.82
0.26
1.5
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
14
114
1.24
0.25
1.6
1.8
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
5
38
1.32
0.23
6.0
2.3
g/l
131.0
131.6
—
5
27
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
91
0.76
0.23
1.4
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
42
1.19
0.21
1.0
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
98
1.23
0.21
1.2
1.9
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3017704) Immunofixation for Urine
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
6
48
1.26
0.20
1.2
1.5
g/l
0.0
0.0
—
6
41
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
554.0
—
0
8
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
40.6
—
0
7
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
259.6
—
0
8
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
6
49
1.23
0.20
1.2
1.5
g/l
0.0
0.0
—
6
41
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
49
1.23
0.20
1.0
1.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
14
118
1.20
0.19
2.4
8.3
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
6
52
1.16
0.19
1.2
1.6
g/l
0.0
0.0
—
6
44
(3021387) Prolactin [Units/volume] in Serum or Plasma
13
109
1.20
0.19
1.8
1.7
mu/l
293.5
336.4
0.43
13
103
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
7
58
1.21
0.18
2.3
1.2
g/l
1.2
1.2
—
7
53
(3021879) Hepatitis B virus core Ab [Presence] in Serum
14
162
0.86
0.16
1.3
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
172
0.86
0.16
1.5
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
72
1.11
0.16
1.1
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
72
1.11
0.16
1.4
1.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
79
0.75
0.15
1.8
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
40
372
1.09
0.15
2.0
2.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
231
0.90
0.13
1.8
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
38
404
0.93
0.12
1.9
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
35
372
0.93
0.11
2.1
3.2
mmol/l
2.4
2.5
0.43
29
325
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
36
339
1.07
0.10
1.9
2.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
47
1.06
0.09
1.0
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
47
1.06
0.09
1.0
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
6
54
1.11
0.09
1.2
1.4
g/l
40.0
37.9
—
6
45
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
6
57
1.05
0.08
1.2
1.6
g/l
0.0
1.6
—
6
48
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
60
0.83
0.08
1.0
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
66
1.06
0.08
1.1
1.6
—
—
—
0
0
(3020891) Body temperature
6
74
0.81
0.07
3.8
4.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
75
0.80
0.07
2.2
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
81
0.86
0.07
1.1
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
87
1.04
0.07
2.2
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
9
88
1.02
0.07
2.1
2.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
15
161
0.93
0.05
1.3
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
15
159
0.94
0.03
4.0
3.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
17
178
0.95
0.02
1.2
1.2
iu/ml
42.8
141.4
—
6
68
(1761868) Lipid panel - Serum or Plasma
83
837
0.99
0.01
2.8
2.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
126
0.95
0.00
1.8
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
156
0.96
0.00
1.0
1.0
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
10
105
0.95
0.00
3.7
8.9
%
1.3
1.5
—
10
105
(3017143) Hepatitis C virus Ab [Presence] in Serum
25
255
0.98
0.00
1.9
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
43
435
0.99
0.00
1.7
1.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
11
106
1.04
0.00
3.5
8.9
%
93.2
94.0
0.13
11
106
(3050129) First trimester maternal screen panel - Serum or Plasma
11
106
1.04
0.00
1.5
1.5
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
11
106
1.04
0.00
3.5
8.8
%
0.6
0.7
0.71
11
106
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
80
1.00
0.00
1.4
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
81
0.99
0.00
1.4
1.4
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
2.6
—
6.5
—
0
5
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
21.1
—
0
6
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
1.9
—
0
5
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
8
0.00
0.00
0.0
6.8
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
58.8
—
0
5
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
0.00
0.0
5.2
—
1.2
—
0
5
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
8
0.00
0.00
0.0
6.8
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
81
0.99
0.00
1.4
1.4
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
10.2
—
24.6
—
0
5
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
80
1.00
0.00
1.4
1.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
7.0
—
0
5
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806420)
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
68
0.88
0.00
1.2
1.3
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
130.5
—
0
8
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.0
—
158.1
—
0
9
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002224) Polysomnography panel
9
92
0.98
0.00
1.0
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
19.4
—
0
5
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
59
1.02
0.00
1.2
1.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4034850)
6
66
0.91
0.00
11.0
9.7
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
8.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
49
490
1.00
0.00
1.9
1.9
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.6
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_VALGUS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_VALGUS | 0.979 [0.79, 1.21] | 0.846 |
| Birth year | 0.994 [0.99, 1.0] | 0.186 |
During the follow-up period (1.1.1998 — 31.12.2019), 113 out of 1234 females with M13_VALGUS died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have M13_VALGUS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.108% | No data |
| 5 | 0.609% | No data |
| 10 | 1.436% | No data |
| 15 | 2.867% | No data |
| 20 | 4.812% | No data |
Relationships between endpoints
↥Index endpoint: M13_VALGUS – Valgus deformity, not elsewhere classified
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data